Rodolfo Sala-Alvarez

La Paz, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Cryobiopsy Outperforms Fine-Needle Aspiration for Mediastinal Lymphadenopathy: A Within-Patient Diagnostic Accuracy Study and Clinical Predictors of Success.

Cryobiopsy Outperforms Fine-Needle Aspiration for Mediastinal Lymphadenopathy: A Within-Patient Diagnostic Accuracy Study and Clinical Predictors of Success.

Journal: Journal of clinical medicine

Published: May 24, 2026

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Journal: Archivos de bronconeumologia

Published: April 27, 2026

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Journal: Journal of investigational allergology & clinical immunology

Published: April 22, 2026

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Journal: Biomedicines

Published: April 22, 2026

Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia.

Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia.

Journal: Open respiratory archives

Published: February 02, 2026

Triglyceride-related lipid changes in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor: A real-world cross-sectional study.

Triglyceride-related lipid changes in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor: A real-world cross-sectional study.

Journal: Clinical nutrition ESPEN

Published: January 12, 2026

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Journal: Archivos de bronconeumologia

Published: December 30, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Inhalers and climate change: A sustainable approach to severe asthma management.

Inhalers and climate change: A sustainable approach to severe asthma management.

Journal: Respiratory medicine

Published: June 05, 2025

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Journal: Journal of clinical medicine

Published: May 29, 2025

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.

Journal: Archivos de bronconeumologia

Published: March 12, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026